NCT03989791 is a NA clinical trial of absolute diet in Polyp Colorectal, sponsored by Nanfang Hospital, Southern Medical University.

Who is sponsoring NCT03989791?

NCT03989791 is sponsored by Nanfang Hospital, Southern Medical University.

What drugs are being tested in NCT03989791?

Interventions in NCT03989791: absolute diet, normal diet.

What condition does NCT03989791 study?

NCT03989791 studies Polyp Colorectal.

Is NCT03989791 still recruiting?

NCT03989791 is currently status unknown. Last updated 18 June 2019.

Last reviewed 2019-06-18 · How we verify

NCT03989791

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Clinical Effect of Normal Diet and Absolute Diet on Post-polypectomy Patients: an Open-label, Randomized Controlled Trial

Status unknown NA Last updated 18 June 2019

What this trial tests

NA trial testing absolute diet in Polyp Colorectal in 406 participants. Status unknown.

Timeline

15 June 2019

Primary endpoint
15 June 2021

20 July 2021

Quick facts

Lead sponsor	Nanfang Hospital, Southern Medical University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	406
Start date	15 June 2019
Primary completion	15 June 2021
Estimated completion	20 July 2021

Drugs / interventions tested

absolute diet
normal diet

Conditions studied

Polyp Colorectal — all drugs for Polyp Colorectal →

Sponsor

Nanfang Hospital, Southern Medical University

Who can join

Adults 18 to 75, any sex, with Polyp Colorectal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no evidence to prove the impact of post-procedural diet on post-polypectomy bleeding (PPB) or delayed perforation. No relevant study has been conducted and it is yet to be determined if absolute diet is necessary for post-polypectomy patients, and the comparison between normal diet and absolute diet also remains unclear. Therefore, we carried out this randomized controlled study to evaluate and compare tthe clinical effect of different diets on post-polypectomy patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Nanfang Hospital, Southern Medical University trials

Trials by the same sponsor.

NCT07091994 — A Trial of Edaravone Dexborneol in Acute Ischemic Stroke With Active Malignancy · Phase 4 · not yet recruiting
NCT06444022 — hAESCs Prevent Acute Graft-versus-host Disease After Hematopoietic Stem Cell Transplantation · Phase 1 · withdrawn
NCT07537777 — Benmelstobart Plus Anlotinib Combined With SBRT for Patients With Hepatocellular Carcinoma Failing First-Line Targeted T · Phase 2 · not yet recruiting
NCT07481032 — Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients · NA · not yet recruiting
NCT07511894 — Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03989791 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nanfang Hospital, Southern Medical University
Last refreshed: 18 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03989791.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing